Theraclion SA (EPA:ALTHE)

Theraclion Statistics

Total Valuation

Theraclion has a market cap or net worth of EUR 30.54 million. The enterprise value is 33.95 million.

Market Cap	30.54M
Enterprise Value	33.95M

Important Dates

The next estimated earnings date is Tuesday, December 23, 2025.

Earnings Date	Dec 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Theraclion has 46.98 million shares outstanding.

Current Share Class	46.98M
Shares Outstanding	46.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	18.71%
Owned by Institutions (%)	6.93%
Float	24.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.29
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.46
EV / Sales	18.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.82

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	58,569
Profits Per Employee	-164,129
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-933,691
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +88.95% in the last 52 weeks. The beta is -0.12, so Theraclion's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	+88.95%
50-Day Moving Average	0.67
200-Day Moving Average	0.45
Relative Strength Index (RSI)	48.31
Average Volume (20 Days)	50,379

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theraclion had revenue of EUR 1.87 million and -5.25 million in losses.

Revenue	1.87M
Gross Profit	-3.30M
Operating Income	-5.97M
Pretax Income	-6.19M
Net Income	-5.25M
EBITDA	-5.55M
EBIT	-5.97M
Earnings Per Share (EPS)	n/a

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -176.20%, with operating and profit margins of -318.54% and -280.23%.

Gross Margin	-176.20%
Operating Margin	-318.54%
Pretax Margin	-330.05%
Profit Margin	-280.23%
EBITDA Margin	-296.30%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Theraclion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-17.20%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1